"VOGLIGOLD 0.3: Effective Postprandial Blood Sugar Control"

VOGLIGOLD 0.3 

Voglibose (0.3mg)

Introduction

VOGLIGOLD 0.3, containing Voglibose (0.3mg), is a highly effective medication for managing type 2 diabetes. This medication helps control postprandial blood glucose levels by delaying the absorption of carbohydrates, making it a crucial part of diabetes management.

Uses

• Improving Glycemic Control: VOGLIGOLD 0.3 is used to enhance glycemic control in adults with type 2 diabetes. It lowers postprandial blood sugar levels by slowing carbohydrate digestion.
• Targeting Postprandial Hyperglycemia: Voglibose is particularly effective in managing postprandial hyperglycemia, which is the rise in blood sugar levels after meals.
• Preventing Diabetes Complications: By effectively managing blood sugar levels, VOGLIGOLD 0.3 helps prevent complications associated with diabetes, such as nerve damage, kidney disease, and heart problems.

Dosage

• Recommended Dosage: The standard dose of VOGLIGOLD 0.3 is one tablet taken three times daily before meals, depending on individual patient needs and response to treatment.
• Method of Administration: It should be taken orally just before meals to maximize its effectiveness in reducing postprandial blood sugar spikes.
• Regular Monitoring: Consistent monitoring of blood glucose levels is essential to ensure the medication's effectiveness and to make necessary dosage adjustments.

Side Effects

• Common Side Effects: Patients may experience gastrointestinal issues such as flatulence, diarrhea, and stomach discomfort. These side effects are generally mild and transient.
• Serious Side Effects: Rare but serious side effects include severe allergic reactions, hypoglycemia, and liver dysfunction. Symptoms such as severe abdominal pain, rapid breathing, and severe dizziness require immediate medical attention.
• Monitoring: Regular check-ups and blood tests are important to monitor kidney and liver function and to detect any potential adverse effects early.

Precautions

• Health Background: Inform your doctor about any pre-existing conditions, particularly gastrointestinal disorders, kidney or liver disease.
• Pregnancy and Nursing: Use of VOGLIGOLD 0.3 during pregnancy should be discussed with your doctor. Consult your healthcare provider before using this medication while breastfeeding.
• Drug Interactions: Provide a comprehensive list of all medications, supplements, and herbal products to your healthcare provider to avoid harmful interactions.

Conclusion

VOGLIGOLD 0.3, with its active ingredient Voglibose (0.3mg), offers an effective solution for managing postprandial blood sugar levels in type 2 diabetes patients. By delaying carbohydrate absorption, this medication helps patients achieve better glycemic control and improve their overall health. Adhering to the prescribed dosage and maintaining regular monitoring are essential for the safe and effective use of VOGLIGOLD 0.3. Always consult with your healthcare provider for personalized advice and report any unusual symptoms promptlSteris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

  For further information: 

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

   BUY NOW